News

Thyroid cancer outcomes worse for black and Hispanic young adults


 

FROM THYROID

References

African American and Hispanic adolescents and adults under the age of 40 years were more likely to die from differentiated thyroid cancer than were non-Hispanic whites from the same age range, said the authors of a newly published study in Thyroid.

Lead author Theresa H.M. Keegan, Ph.D., of Stanford (Calif.) University and her associates used the California Cancer Registry to obtain data on 16,827 adolescents and young adults who had a diagnosis of differentiated thyroid cancer between 1988 and 2010. Older young adults aged 35-39 years (versus 15- to 29-year-olds), men (hazard ratio, 2.77; 95% confidence interval, 1.62-4.72), and adolescents and young adults of African American or Hispanic race/ethnicity (versus non-Hispanic whites) had worse thyroid cancer–specific survival than did non-Hispanic whites, judging from findings of multivariate analyses using Cox proportional hazards regression.

In addition, residence in low-socioeconomic-status neighborhoods (HR, 3.11; 95% CI, 1.28-7.56) and nonmetropolitan areas (HR, 5.53; 95% CI, 2.07-14.78) was associated with worse thyroid cancer–specific survival among adolescent and young adult men but not adolescent and young adult women.

“Our study is one of the first to simultaneously consider the impact of small-area neighborhood [socioeconomic status], health insurance, marital status, diagnosis of subsequent cancers, and a number of tumor characteristics on survival after” differentiated thyroid cancer in adolescents and young adults, the authors noted.

Read the full article here (Thyroid 2015;25:635-48 [doi:10.1089/thy.2015.0021]).

The authors reported that they did not have any competing financial interests.

mbock@frontlinemedcom.com

Recommended Reading

Nonfunctioning pituitary adenoma linked to higher mortality in women
MDedge Endocrinology
New guidelines address hypopituitarism in TBI
MDedge Endocrinology
Copeptin levels predicted diabetes insipidus after pituitary surgery
MDedge Endocrinology
AACE: Free testosterone, prolactin levels signal MRI need in men with secondary hypogonadism
MDedge Endocrinology
AACE: Artificial sweeteners tentatively linked to Hashimoto’s thyroiditis
MDedge Endocrinology
Subclinical hyperthyroidism linked to higher fracture risk
MDedge Endocrinology
Thyroid surgery on the rise
MDedge Endocrinology
AACE: Endocrine treatment of childhood cancer survivors needs improvement
MDedge Endocrinology
AACE: How to safely skip radioactive iodine for low-grade thyroid cancer
MDedge Endocrinology
ASA: Mutation testing aids decision making in thyroid cancer
MDedge Endocrinology